StockWatch
·
Biotechnology: Pharmaceutical Preparations
ESOPJul 1, 2026, 04:02 PM

Damora Grants 453,500 Stock Options to 9 New Employees

AI Summary

Damora Therapeutics, Inc. announced it granted equity awards to nine newly-hired, non-executive employees on July 1, 2026. These inducement grants, approved by the Compensation Committee, consist of non-qualified stock options to purchase an aggregate of 453,500 shares of common stock. The options have a 10-year term and an exercise price of $26.01 per share, vesting over four years.

Key Highlights

  • Damora granted equity awards to nine newly-hired, non-executive employees.
  • The inducement grants consist of non-qualified stock options.
  • Options are to purchase an aggregate of 453,500 shares of common stock.
  • The exercise price for the options is $26.01 per share.
  • Options have a 10-year term.
  • Vesting schedule: 25% on the first anniversary, then equal monthly installments for 36 months.